ConnectMed

Telemedicine platform.

🇰🇪 Kenya Health TechAcquired and discontinued

Epitaph

“Here lies ConnectMed. It gave patients in Kenya and South Africa video consultations, same-day prescriptions, and referrals through licensed doctors. Adoption stayed thin and profit thinner, until Merck absorbed its technology into the Curafa network. Its final referral was to a new owner.”

Overview

Born: 2017 (Year)
Died: August 2016 (Month)
Fate: Acquired and discontinued
Headquarters: 🇰🇪 Kenya
Category: Health Tech
Stage at death: Seed
Primary cause: Business model or unit economics
Contributing causes: No product-market fit, Funding or runway, Acquisition or strategy change

Death certificate

Timeline

2017Founded
ConnectMed launches its telehealth platform in Kenya
September 2018Merck launches Curafa
Merck's Curafa points-of-care network launches in Kenya, later becoming the acquirer's platform
December 2018Operations wind down
Some reporting places the operational handover around this time
April 2019Acquisition announced
Merck KGaA announces acquisition of ConnectMed's telehealth technology

Autopsy report

Why did ConnectMed shut down?

Kenyan telehealth startup ConnectMed, founded in 2017 and backed by over $300,000 from accelerators and academic centers, was acquired by German pharmaceutical giant Merck KGaA in a deal announced in April 2019 to fold its telehealth technology into Merck's Curafa points-of-care network, after which ConnectMed ceased operating as an independent company.

What ConnectMed attempted

ConnectMed offered direct-to-consumer telemedicine in Kenya and South Africa, letting patients get video consultations, same-day prescriptions, sick notes, and referrals from licensed doctors, integrated with over 30 pharmacy locations.

What worked

Served more than 8,000 patients and corporate clients; raised over $300,000 in backing from the University of Cape Town's Bertha Centre, the University of Oxford's Skoll Centre, Entrepreneur First, and Katapult Accelerator; ultimately attracted acquisition interest from Merck KGaA.

Early warning signs

Sources cited low telemedicine adoption, patient preference for in-person consultations, and limited internet access and digital literacy in target markets as ongoing obstacles, alongside difficulty scaling to profitability despite the funding raised.

What happened

ConnectMed grew its direct-to-consumer telehealth service to over 8,000 patients across Kenya and South Africa but struggled to scale profitably given low market adoption. Merck KGaA acquired ConnectMed's telehealth technology and platform, announced in April 2019, to integrate into its Curafa points-of-care network (launched September 2018); ConnectMed then ceased operating independently and CEO Melissa McCoy subsequently joined Google.

Lessons for future builders

Telehealth can serve thousands and still not reach profitability where in-person care is preferred and connectivity is patchy. Prove a path to sustainable margins in the real market before scaling, and treat acquisition as one plan, not the fallback for unproven economics.